Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate three things. The first being whether azacitidine is
absorbed in the body at the same rate or proportion for different concentrations. The second
is to determine the effect renal impairment has or does not have on the absorption of
azacitidine. The third is to determine if azacitidine is safe and well tolerated in patients
with renal function impairment.